Sec Form 13G Filing - Feis Lawrence filing for CITIUS ONCOLOGY INC. (CTOR) - 2023-02-08

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o  Rule 13d-1(b)

ý  Rule 13d-1(c)

o  Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1

2

3

Item 1.

The name and address of the principal executive offices of the Issuer are:

TenX Keane Acquistion

420 Lexington Ave, Suite 2446

New York, NY  10170

Item 2.

This statement on Schedule 13G is being filed by:

(a) Name of Person Filing 

(i)Feis Equities LLC 

(ii)Lawrence M. Feis 

4

Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)oBroker or dealer registered under section 15 of the Act (15 U.S.C. 78o). 

(b)oBank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). 

(c)oInsurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). 

(d)oInvestment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). 

(e)oAn investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); 

(f)oAn employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); 

(g)oA parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); 

(h)oA savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); 

(i)oA church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); 

(j)oGroup, in accordance with §240.13d-1(b)(1)(ii)(J). 

Item 4.  Ownership

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for each Reporting Person and incorporated by reference herein.

The percentage set forth in row 11 of the cover page for each Reporting Person is based on 8,941,000 Ordinary shares outstanding as of November 28,2022, as reported by the Issuer in its quarterly 10-Q filing for the period ending September 30, 2022, filed with the Securities and Exchange Commission on November 28, 2022.

5

Item 5.  Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  o

Item 6.  Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not applicable.

Item 8.  Identification and Classification of Members of the Group

Not applicable.

Item 9.  Notice of Dissolution of Group

Not applicable.

Item 10.  Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

6

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

7

EXHIBIT INDEX

8

JOINT FILING AGREEMENT

The undersigned hereby agree that the statement on Schedule 13G with respect to the Ordinary shares of TenX Keane Acquistion dated as of February 6, 2023 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

FEIS EQUITIES LLC 

By:/s/ Lawrence M. Feis 

Managing Member LLC 

LAWRENCE M. FEIS 

By:/s/ Lawrence M. Feis 

Date:  February 6, 2023

9